Your browser doesn't support javascript.
loading
Author Correction: Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote TH2 and inhibit TH17 cell polarization.
Mayer, Johannes U; Hilligan, Kerry L; Chandler, Jodie S; Eccles, David A; Old, Samuel I; Domingues, Rita G; Yang, Jianping; Webb, Greta R; Munoz-Erazo, Luis; Hyde, Evelyn J; Wakelin, Kirsty A; Tang, Shiau-Choot; Chappell, Sally C; von Daake, Sventja; Brombacher, Frank; Mackay, Charles R; Sher, Alan; Tussiwand, Roxane; Connor, Lisa M; Gallego-Ortega, David; Jankovic, Dragana; Le Gros, Graham; Hepworth, Matthew R; Lamiable, Olivier; Ronchese, Franca.
Afiliación
  • Mayer JU; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Hilligan KL; Department of Dermatology and Allergology, Phillips University Marburg, Marburg, Germany.
  • Chandler JS; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Eccles DA; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Old SI; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Domingues RG; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Yang J; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Webb GR; Lydia Becker Institute of Immunology and Inflammation, Manchester Collaborative Centre for Inflammation Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Munoz-Erazo L; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Hyde EJ; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Wakelin KA; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Tang SC; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Chappell SC; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • von Daake S; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Brombacher F; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Mackay CR; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Sher A; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town component & Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa.
  • Tussiwand R; Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia.
  • Connor LM; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Gallego-Ortega D; Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Jankovic D; Immune Regulation Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
  • Le Gros G; Malaghan Institute of Medical Research, Wellington, New Zealand.
  • Hepworth MR; School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.
  • Lamiable O; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
  • Ronchese F; Centre for Single-Cell Technology, School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Ultimo, NSW, Australia.
Nat Immunol ; 23(6): 985, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35418649

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Nat Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda